Journal of the American Academy of Dermatology

Clinicians should still be mindful of new gastrointestinal symptoms and monitor for possible IBD, particularly during the first year of treatment.

Our next study, published in the Journal of the American Academy of Dermatology, is titled Effectiveness and Safety of Tofacitinib as Adjunctive Therapy for DRESS, a Real-World Study.

DRESS is a potentially life-threatening drug hypersensitivity reaction, and systemic steroids remain first-line treatment.

But prolonged steroid courses can come with significant toxicity, and patients may relapse during tapering.

They were forcing them to eat this stuff.

And according to Dr. Lin, it would, quote, "Take an individual," human being, I imagine, "277 years of sunscreen use to achieve the same dose that produced the harmful effects in these rats." And that's based on a study from the Journal of the American Academy of Dermatology in 2017.

But think carefully, right? 2017.

It's a number of years ago.

That's a great question.

We recently published a study in the Journal of American Academy of Dermatology.

This was a retrospective study of about 40,000 patients from the Trinadex research database, where We compared 20,000 patients with psoriasis who never got a GLP-1 receptor agonist and about 20,000 patients with psoriasis who did.

And we have followed these patients for about 10 years.